Correlation Between Metacrine and NovaBay Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Metacrine and NovaBay Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Metacrine and NovaBay Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Metacrine and NovaBay Pharmaceuticals, you can compare the effects of market volatilities on Metacrine and NovaBay Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Metacrine with a short position of NovaBay Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Metacrine and NovaBay Pharmaceuticals.
Diversification Opportunities for Metacrine and NovaBay Pharmaceuticals
-0.08 | Correlation Coefficient |
Good diversification
The 3 months correlation between Metacrine and NovaBay is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Metacrine and NovaBay Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NovaBay Pharmaceuticals and Metacrine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Metacrine are associated (or correlated) with NovaBay Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NovaBay Pharmaceuticals has no effect on the direction of Metacrine i.e., Metacrine and NovaBay Pharmaceuticals go up and down completely randomly.
Pair Corralation between Metacrine and NovaBay Pharmaceuticals
If you would invest 49.00 in Metacrine on September 23, 2024 and sell it today you would earn a total of 0.00 from holding Metacrine or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 4.76% |
Values | Daily Returns |
Metacrine vs. NovaBay Pharmaceuticals
Performance |
Timeline |
Metacrine |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
NovaBay Pharmaceuticals |
Metacrine and NovaBay Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Metacrine and NovaBay Pharmaceuticals
The main advantage of trading using opposite Metacrine and NovaBay Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Metacrine position performs unexpectedly, NovaBay Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NovaBay Pharmaceuticals will offset losses from the drop in NovaBay Pharmaceuticals' long position.Metacrine vs. Protara Therapeutics | Metacrine vs. CytomX Therapeutics | Metacrine vs. Assembly Biosciences | Metacrine vs. Instil Bio |
NovaBay Pharmaceuticals vs. Oric Pharmaceuticals | NovaBay Pharmaceuticals vs. Lyra Therapeutics | NovaBay Pharmaceuticals vs. Inhibrx | NovaBay Pharmaceuticals vs. ESSA Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |